HIRBOD BEHBAHANINIA: Open Payments
NPI 1770045825 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,081 in 64 payments from 12 companies in 2025. Trend: 2023 $663 · 2024 $1,339 · 2025 $2,081
Food & beverage: $1,882Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $616 |
| Sumitomo Pharma America, Inc. | 10 | $246 |
| ACCORD HEALTHCARE, INC. | 8 | $227 |
| PFIZER INC. | 5 | $202 |
| Astellas Pharma US Inc | 5 | $176 |
| Ferring Pharmaceuticals Inc. | 3 | $158 |
| ABBVIE INC. | 5 | $157 |
| Endo USA, Inc. | 7 | $148 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $83 |
| 180 Medical, Inc. | 1 | $27 |
Products named: ERLEADA, RYBREVANT, XTANDI, GEMTESA, Camcevi, ADSTILADRIN, XIAFLEX, BOTOX.
Industry payments across AZ — which companies pay providers there.
